Results from the first phase 1 clinical study of the B-cell maturation antigen (BCMA) NEX T chimeric antigen receptor (CAR) T cell therapy CC-98633/BMS-986354 in patients (pts) with relapsed/refractory multiple myeloma (RRMM) Meeting Abstract
| Authors: | Costa, L. J.; Kumar, S. K.; Atrash, S.; Liedtke, M.; Kaur, G.; Derman, B. A.; Bergsagel, P. L.; Mailankody, S.; McCarthy, P. L.; Limones, J.; Chen, Y.; Das, S.; Thorpe, J.; Cacciatore, J.; Navarro, G.; Koegel, A. K.; Burgess, M. R.; Hege, K.; Richard, S. |
| Abstract Title: | Results from the first phase 1 clinical study of the B-cell maturation antigen (BCMA) NEX T chimeric antigen receptor (CAR) T cell therapy CC-98633/BMS-986354 in patients (pts) with relapsed/refractory multiple myeloma (RRMM) |
| Meeting Title: | 64th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 140 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2022 Dec 10-13 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2022-11-15 |
| Start Page: | 1360 |
| End Page: | 1362 |
| Language: | English |
| ACCESSION: | WOS:000893223201152 |
| DOI: | 10.1182/blood-2022-160038 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
